Frederick G. Vogt is CEO & CLO at IOVANCE BIOTHERAPEUTICS, INC. (IOVA). They have made 3 open-market trades across 1 company since 2022, most recently 2026-09-08.
CIK 0001719678
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $55K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IOVA | 595,447 | $8.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-10 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.